archives
Neurocrine Announces Peer-Reviewed Publication of Indiplon ...
Submitted by admin on Wed, 2006-04-05 12:00.... Neurocrine Announces Peer-Reviewed Publication of Indiplon Mechanism of Action
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms ...
Pharmos Sets Strategic Priorities for Development of Vela ...
Submitted by admin on Wed, 2006-04-05 14:00.... Pharmos Sets Strategic Priorities for Development of Vela Compounds: Financial News - Yahoo! Finance
Pharmos Sets Strategic Priorities for Development of Vela Compounds
Copyright 2006 Yah ...
Marinova seeks nutraceutical partners for fucoidans
Submitted by admin on Wed, 2006-04-05 16:00.... ...
Herbal Therapy (CHT) Versus Placebo in Patients With Irritable ...
Submitted by admin on Thu, 2006-04-06 00:00.... irritable bowel syndrome, relative to placebo
Secondary Outcomes: 30% change on the IBS-36 from baseline to 4 weeks (“no” or “yes”); Change on IBS-36 from 4 weeks (last treatment taken) and 8 we ...
